Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 May;112(1):49–54. doi: 10.1111/j.1476-5381.1994.tb13027.x

Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.

M D Randall 1, H Ujiie 1, T M Griffith 1
PMCID: PMC1910280  PMID: 8032661

Abstract

1. We have used a rabbit isolated ear, buffered-perfused preparation to investigate the effects of adenosine analogues on the vasodilatation to the potassium channel opener, levcromakalim (the active (-)-enantiomer of cromakalim). We have examined the effects of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective adenosine A1 antagonist, on vasodilatation to levcromakalim under hypoxic conditions and also following inhibition of nitric oxide synthesis. 2. Levcromakalim relaxed preconstricted preparations with an EC50 = 369 +/- 48 nM and maximum relaxation of tone (Rmax) = 81.0 +/- 3.2%. In the presence of 1 microM N6-cyclohexyladenosine (CHA) a selective adenosine A1 agonist, there was a significant (P < 0.01) leftward shift in the concentration-response curve with an EC50 = 194 +/- 54 nM and Rmax = 93.2 +/- 2.0%. Conversely, the presence of CHA did not influence vasodilatation to either pinacidil or sodium nitroprusside. 3. Hypoxia also significantly (P < 0.001) increased the vasodilator potency of levcromakalim (EC50 = 134 +/- 22 nM), and this enhancement was completely reversed (EC50 = 380 +/- 107 nM, P < 0.01) by pretreatment of the preparations with 5 microM DPCPX, a selective A1 adenosine antagonist. However, under normoxic conditions DPCPX did not influence vasodilatation to levcromakalim. 4. Inhibition of nitric oxide synthesis with 100 microM NG-nitro-L-arginine methyl ester (L-NAME) caused a significant (P < 0.001) leftward shift in the concentration-response curve to levcromakalim (EC50 = 73.0 +/- 7.6 nM). Pretreatment of preparations with DPCPX partially reversed the increase in potency found in the absence of nitric oxide synthesis (EC50 = 153 +/- 18 nM, P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angerbach D., Nicholson C. D. Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease. Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):341–346. doi: 10.1007/BF00168848. [DOI] [PubMed] [Google Scholar]
  2. Bardenheuer H., Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol. 1986 Feb;250(2 Pt 2):H173–H180. doi: 10.1152/ajpheart.1986.250.2.H173. [DOI] [PubMed] [Google Scholar]
  3. Berne R. M. The role of adenosine in the regulation of coronary blood flow. Circ Res. 1980 Dec;47(6):807–813. doi: 10.1161/01.res.47.6.807. [DOI] [PubMed] [Google Scholar]
  4. Dart C., Standen N. B. Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J Physiol. 1993 Nov;471:767–786. doi: 10.1113/jphysiol.1993.sp019927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edwards G., Weston A. H. Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther. 1990;48(2):237–258. doi: 10.1016/0163-7258(90)90082-d. [DOI] [PubMed] [Google Scholar]
  6. Fujino K., Nakaya S., Wakatsuki T., Miyoshi Y., Nakaya Y., Mori H., Inoue I. Effects of nitroglycerin on ATP-induced Ca(++)-mobilization, Ca(++)-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery. J Pharmacol Exp Ther. 1991 Jan;256(1):371–377. [PubMed] [Google Scholar]
  7. Gardiner S. M., Kemp P. A., Bennett T. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol. 1991 Nov;104(3):731–737. doi: 10.1111/j.1476-5381.1991.tb12496.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Garland C. J., McPherson G. A. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 1992 Feb;105(2):429–435. doi: 10.1111/j.1476-5381.1992.tb14270.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Griffith T. M., Edwards D. H., Davies R. L., Harrison T. J., Evans K. T. EDRF coordinates the behaviour of vascular resistance vessels. Nature. 1987 Oct 1;329(6138):442–445. doi: 10.1038/329442a0. [DOI] [PubMed] [Google Scholar]
  10. Kirsch G. E., Codina J., Birnbaumer L., Brown A. M. Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol. 1990 Sep;259(3 Pt 2):H820–H826. doi: 10.1152/ajpheart.1990.259.3.H820. [DOI] [PubMed] [Google Scholar]
  11. Komori K., Lorenz R. R., Vanhoutte P. M. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol. 1988 Jul;255(1 Pt 2):H207–H212. doi: 10.1152/ajpheart.1988.255.1.H207. [DOI] [PubMed] [Google Scholar]
  12. Kostic M. M., Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res. 1992 Jan;70(1):208–212. doi: 10.1161/01.res.70.1.208. [DOI] [PubMed] [Google Scholar]
  13. Lawson K., Barras M., Zazzi-Sudriez E., Martin D. J., Armstrong J. M., Hicks P. E. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers. Br J Pharmacol. 1992 Sep;107(1):58–65. doi: 10.1111/j.1476-5381.1992.tb14463.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Longman S. D., Clapham J. C., Wilson C., Hamilton T. C. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil. J Cardiovasc Pharmacol. 1988;12(5):535–542. [PubMed] [Google Scholar]
  15. Marshall J. M., Thomas T., Turner L. A link between adenosine, ATP-sensitive K+ channels, potassium and muscle vasodilatation in the rat in systemic hypoxia. J Physiol. 1993 Dec;472:1–9. doi: 10.1113/jphysiol.1993.sp019931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McPherson G. A., Angus J. A. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol. 1990 Jun;100(2):201–206. doi: 10.1111/j.1476-5381.1990.tb15782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Merkel L. A., Lappe R. W., Rivera L. M., Cox B. F., Perrone M. H. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J Pharmacol Exp Ther. 1992 Feb;260(2):437–443. [PubMed] [Google Scholar]
  18. Mian R., Marshall J. M. The role of adenosine in dilator responses induced in arterioles and venules of rat skeletal muscle by systemic hypoxia. J Physiol. 1991 Nov;443:499–511. doi: 10.1113/jphysiol.1991.sp018847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nichols C. G., Lederer W. J. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 1991 Dec;261(6 Pt 2):H1675–H1686. doi: 10.1152/ajpheart.1991.261.6.H1675. [DOI] [PubMed] [Google Scholar]
  20. Pavlovic D., Brione E., De Vernejoul D., Aubier M. Partial inhibition by epithelium of tracheal smooth muscle relaxation induced by the potassium channel activator, BRL 38227. Br J Pharmacol. 1993 Sep;110(1):139–144. doi: 10.1111/j.1476-5381.1993.tb13783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Randall M. D., Griffith T. M. Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity. Br J Pharmacol. 1991 Nov;104(3):743–749. doi: 10.1111/j.1476-5381.1991.tb12498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Randall M. D., Griffith T. M. Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear. Br J Pharmacol. 1992 Jun;106(2):315–323. doi: 10.1111/j.1476-5381.1992.tb14334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Randall M. D., Griffith T. M. Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil. Br J Pharmacol. 1993 Jun;109(2):386–393. doi: 10.1111/j.1476-5381.1993.tb13581.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sturgess N. C., Ashford M. L., Cook D. L., Hales C. N. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985 Aug 31;2(8453):474–475. doi: 10.1016/s0140-6736(85)90403-9. [DOI] [PubMed] [Google Scholar]
  25. Tare M., Parkington H. C., Coleman H. A., Neild T. O., Dusting G. J. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 1990 Jul 5;346(6279):69–71. doi: 10.1038/346069a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES